University of Tokyo Edge Capital (UTec), the institution’s VC arm, has taken part in a ¥440m ($4m) funding round for Singapore-based healthcare analytics company Tricog Health, Nikkei Asian Review reported yesterday.

The identity of UTec’s co-investors has not been revealed.

Tricog Health has developed a cloud-based platform that relies on artificial intelligence technology to determine a patient’s risk of heart disease by analysing electrocardiograms (ECGs).

The platform compares ECG results to a database of existing diagnoses and flags high-risk individuals to Tricog’s doctors who manually provide a final diagnosis. The company claims its platform can offer a diagnosis within six minutes.

The service is particularly relevant for clinics in remote locations where no heart disease specialists are on hand.

It is currently available across 12 countries and while the platform is currently only compatible with ECG machines made by conglomerate General Electric, Tricog hopes to make it compatible with machines made in Japan.

Tricog will use the strategic relationship with UTec to explore opportunities in Japan. The company is particularly keen on targeting UTec’s network of medical device manufacturers and healthcare providers.

Tricog previously obtained an undisclosed amount in series A funding in 2016 from Inventus Capital Partners, Blume Ventures and assorted angel investors.